Global News

Bio-Optronics, Schulman Associates IRB to simplify clinical trial management

Friday, May 3, 2013 11:30 AM

Bio-Optronics, a software and services provider, and Schulman Associates IRB, an international, AAHRPP-accredited independent IRB, announced their partnership and their newly integrated regulatory compliance module for the Clinical Conductor Enterprise CTMS application. This collaboration offers Clinical Conductor Enterprise CTMS users streamlined IRB interactions from one centralized location.

More... »

Soligenix, Intrexon pursue melioidosis therapy through exclusive collaboration

Friday, May 3, 2013 10:48 AM

Soligenix, a clinical stage biopharmaceutical company focused on inflammatory diseases and biodefense countermeasures, will jointly develop a treatment for melioidosis through a worldwide exclusive collaboration with Intrexon, a synthetic biology company that utilizes its proprietary technologies to provide control over cellular function.

More... »

Abide Therapeutics, Merck to develop novel therapies for T2D, metabolic diseases

Friday, May 3, 2013 10:19 AM

Abide Therapeutics, a biopharmaceutical company pioneering innovative approaches to selectively target a group of enzymes known as serine hydrolases, has entered into a collaboration agreement with Merck, to discover, develop and commercialize small-molecule therapies directed against three novel targets to treat metabolic diseases with a focus on type 2 diabetes.

More... »

Sitrof Technologies joins EMC Information Intelligence Group C3P

Friday, May 3, 2013 09:02 AM

Sitrof Technologies, a provider of IT and content management solutions, has been selected to join the EMC Information Intelligence Group Consulting Preferred Partner Program (C3P).

More... »

Natera completes $54.6M financing for global rollout of Panorama prenatal test

Wednesday, May 1, 2013 02:46 PM

Natera, a genetic testing company, has completed a $54.6 million financing round to support the expansion and continued global rollout of Natera's non-invasive prenatal test, Panorama. The financing round included two new lead investors, OrbiMed Advisors and Harmony Partners, as well as other undisclosed new investors. All existing investors participated, including Claremont Creek Ventures, Lightspeed Venture Partners, Founders Fund and Sequoia Capital.

More... »

IMS Health advances cloud-based social media analytics with acquisition of Semantelli

Wednesday, May 1, 2013 02:09 PM

IMS Health, a provider of information, services and technology for the healthcare industry, has acquired Semantelli, a Bridgewater, N.J.-based social media analytics company, to extend its marketing and consumer engagement capabilities for healthcare organizations around the world.

More... »

Aerocrine completes $50M debt and equity financing

Wednesday, May 1, 2013 10:58 AM

Aerocrine, a medical products company, has completed a financing with an affiliate of the U.S. investment firm OrbiMed Advisors and with Novo consisting of $35 million of debt. Aerocrine also raised $ 15 million of equity from OrbiMed and a number of institutional investors through a directed share issue.

More... »

Qiagen acquires Ingenuity Systems

Wednesday, May 1, 2013 10:30 AM

Qiagen, a Netherlands-based global provider of sample and assay technologies, has acquired Ingenuity Systems, a Redwood City, Calif.-based provider of software solutions to efficiently and accurately analyze and interpret the biological meaning of genomic data.

More... »

Parexel International acquires Heron Group

Wednesday, May 1, 2013 09:57 AM

Parexel International, a global CRO, has acquired all outstanding equity securities of the Heron Group, a Luton, U.K.-based life sciences consultancy that provides evidence-based commercialization services to support biopharmaceutical companies throughout the lifecycle of their products. 

More... »

Investigative sites rate INC Research, PPD, inVentiv top CROs in new CenterWatch study

Wednesday, May 1, 2013 09:12 AM

More than 2,000 global investigative sites rated the best CROs to work for in a new study conducted by CenterWatch, a provider of global clinical trials information. Detailed results of the study were released in the May issue of The CenterWatch Monthly.

More... »